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SUMMARY
Nitricoxide (NO) regulatesprotein functionbyS-nitro-
sylation of cysteine to form nitrosothiols. Nitroso-
thiols are highly susceptible to nonenzymatic degra-
dation by cytosolic reducing agents. Here we show
that although most protein nitrosothiols are rapidly
degraded by cytosolic reductants, a small subset
form unusually stable S-nitrosylated proteins. Our
findings suggest that stable S-nitrosylation reflects
a protein conformation change that shields the nitro-
sothiol. To identify stable protein nitrosothiols,
we developed a proteomic method for profiling
S-nitrosylation. We examined the stability of over
100 S-nitrosylated proteins, and identified 10 stable
nitrosothiols. Theseproteins remainedS-nitrosylated
in cells after NO synthesis was inhibited, unlike most
S-nitrosylated proteins. Taken together, our data
identify a class of NO targets that form stable nitroso-
thiols in the cell and are likely to mediate the persis-
tent cellular effects of NO.
INTRODUCTION
The primary mechanism by which NO exerts its diverse physio-
logical effects is by chemical modification of specific effector
proteins. A prominent NOmodification is the nitrosylation of cys-
teine residues, called S-nitrosylation. This reversible modifica-
tion can affect protein activity, localization, or stability (Hess
et al., 2005). S-nitrosylation can be elicited nonenzymatically,
for example by NO-derived nitrosating species, such as N2O3,
or by transnitrosylation, in which a nitrosyl moiety of an existing
nitrosothiol is transferred to a protein thiol (Foster et al., 2003;
Mitchell and Marletta, 2005). Alternatively, examples of enzy-
matic pathways leading to the formation of protein nitrosothiols
(Pawloski et al., 2001) or small-molecule nitrosothiols (Inoue
et al., 1999) have been described. The specificity of S-nitrosyla-
tion is governed by several mechanisms, including consensus
sequences that increase the chemical reactivity of cysteine
targets of NO (Stamler et al., 1997b) and adaptor proteins that
juxtapose NO synthase (NOS) isoenzymes to their targets (Paige
and Jaffrey, 2007). Over 100 proteins have been reported to be
S-nitrosylated in mammalian cells, likely accounting for many
of the observed effects of NO in cells (Stamler et al., 2001).
Much less is known about how protein denitrosylation is
elicited in cells. Denitrosylation reverses S-nitrosylation, and
therefore affects the duration of NO signaling in cells. Addition-
ally, the steady-state concentration of the nitrosylated form of
a protein is determined by the rates of both S-nitrosylation and
denitrosylation, making denitrosylation a critical determinant of
the effectiveness of a NO signal. Because nitrosothiols are a re-
versible oxidative modification, they are predicted to be unstable
in the highly reducing environment of the cytosol, which contains
numerous small-molecule reductants (Sen, 1998). Indeed, the
levels of some protein nitrosothiols in cells are directly regulated
by the intracellular concentration of the cytosolic reducing agent
glutathione (GSH) (Clementi et al., 1998), which can be present at
0.5–10 mM (Kosower and Kosower, 1978; Mayer et al., 1995).
Consistent with this prediction, small-molecule nitrosothiols
have half-lives of seconds to minutes in biological solutions (Ka-
shiba-Iwatsuki et al., 1997; Singh et al., 1996). Because the
chemical properties of nitrosothiols might be expected to be
the same in small molecules and in the context of proteins, it is
plausible that cytosolic protein S-nitrosylation is followed by
rapid nonenzymatic denitrosylation due to cytosolic reductants.
Despite this prediction, two protein-mediated mechanisms
have been identified for denitrosylation in cells. The first mecha-
nism involves S-nitrosoglutathione (GSNO) reductase, a highly
conserved enzyme capable of denitrosylating GSNO in vivo
(Liu et al., 2001). Additionally, recent studies of caspase-3
have highlighted a second denitrosylation mechanism. In an
in vitro study, Marletta and colleagues (Mitchell and Marletta,
2005) found that the S-nitrosylated form of caspase-3 could
not be reduced by in vitro application of GSH (Mitchell and Mar-
letta, 2005). Instead, thioredoxin, a protein that can catalyze thiol
reduction, was capable of eliciting caspase-3 denitrosylation
(Mitchell and Marletta, 2005). Stamler and colleagues recently
showed that thioredoxin reductases/thioredoxins are physio-
logic caspase-3 denitrosylases (Benhar et al., 2008). These
studies indicate that protein nitrosothiols might exhibit different
reactivity toward reductants than small-molecule nitrosothiols.
However, it remains unclear whether nitrosothiol stability is
rare or a general property of protein nitrosothiols.
To understand how S-nitrosylation serves as an effector path-
way of NO in cells, the chemical reactivity of protein nitrosothiols
needs to be understood. To profile the chemical properties of
S-nitrosylated proteins, we devised a proteomic approach to
survey the reactivity of over 100 protein nitrosothiols. Our find-
ings reveal that nitrosothiols in proteins can be classified as
either ‘‘stable’’ or ‘‘unstable,’’ with the stable nitrosothiols
appearing to result from conformational changes that reduce
the accessibility of the nitrosothiol to solvent. We find that these
chemically stable protein nitrosothiols are also stable in cells,
thereby identifying a subset of S-nitrosylated proteins thatChemistry & Biology 15, 1307–1316, December 22, 2008 ª2008 Elsevier Ltd All rights reserved 1307
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Proteomic Profiling of S-Nitrosylationcan carry the NO signal even after NO signaling has ended and
likely utilize specific denitrosylation pathways to terminate NO
signaling.
RESULTS
A Subset of Protein Nitrosothiols Show Significantly
Reduced GSH Reactivity
To better understand the properties of nitrosothiols in proteins,
we examined the ability of GSH to reduce different protein nitro-
sothiols. We first generated a population of S-nitrosylated pro-
teins using GSNO, a physiological NO donor (Gaston et al.,
1993; Kluge et al., 1997). GSNOwas used because it is expected
to catalyze the formation of a wide range of S-nitrosylated
proteins (Hao et al., 2006; Jaffrey et al., 2001). As described pre-
viously, S-nitrosylated proteins were prepared by incubating
brain cytosolic lysates with 40 mM GSNO and then removing
the GSNO with a desalting column (Jaffrey et al., 2001).
To characterize the reactivity of these protein nitrosothiols, we
assessed their ability to be denitrosylated following incubation
with 1 mM GSH. Protein nitrosothiols were detected using the
biotin switch method, which introduces a biotin moiety on cyste-
ines that are S-nitrosylated (Figure 1A) (Jaffrey et al., 2001). Each
of the bands detected in the biotin switch assay is dependent
upon ascorbate treatment, consistent with the ascorbate-
dependent reduction of nitrosothiol bonds (see Figure S1A avail-
able online) (Jaffrey et al., 2001). GSH treatment resulted in rapid
and essentially complete denitrosylation of most proteins after
5 min (Figure 1B). Surprisingly, a small subset of proteins re-
mained S-nitrosylated even after 30 min of GSH exposure (Fig-
ures 1B and 1C). Higher concentrations of GSHor higher temper-
atures did not reduce the stability of these protein nitrosothiols
(Figures S1B–S1E). Using densitometry measurements, we
classified the degree of denitrosylation after 30 min into five
categories: 0%–20%, 21%–40%, 41%–60%, 61%–80%, and
81%–100%. Nearly all proteins exhibited either 81%–100% or
0%–20% reduction of S-nitrosylation, which we termed unstable
nitrosothiols or stable nitrosothiols, respectively (Figure 1D).
Together, thesedata indicate that, unlike small-molecule nitroso-
thiols, which are rapidly denitrosylated (Kashiba-Iwatsuki et al.,
1997; Singh et al., 1996), protein nitrosothiols have different reac-
tivities and that a subset of proteins form nitrosothiols that have
significantly reduced susceptibility to GSH reduction.
Stable Nitrosothiols Appear Conformationally Protected
from Reducing Agents
To characterize the basis for the reduced reactivity of the GSH-
stable nitrosothiols, we used 2-mercaptoethanol (2-ME), a
considerably smaller reducing agent that should more easily
gain access to buried nitrosothiols. Treatment of S-nitrosylated
D
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A Figure 1. A Subset of Protein Nitrosothiols
Are Resistant to GSH-Mediated Denitrosy-
lation
(A) Schematic diagram of the biotin switch method
(Jaffrey et al., 2001). A theoretical protein is
indicated with cysteines in either the free-thiol,
disulfide, or nitrosothiol conformation. In step 1, all
nonnitrosylated thiolsareblockedwithmethylmeth-
anethiosulfonate (MMTS) in the presence of SDS to
ensureaccessofMMTS to internal cysteines.Under
the conditions used, MMTS does not react with
nitrosothiols or preexisting disulfide bonds. In step
2, residual MMTS is removed by acetone precipita-
tion and nitrosothiol bonds are selectively decom-
posedwith ascorbate,which results in the reduction
of nitrosothiols to thiols. In step 3, the thiols that re-
main derive exclusively from formerlyS-nitrosylated
cysteines, and are then labeled with the thiol-spe-
cific biotinylation reagent N-(6-(biotinamido)hexyl)-
30-(20-pyridyldithio)-propionamide (biotin-HPDP).
(B) Detection of a subset of stably S-nitrosylated
proteins. Lysates were exposed to 40 mM GSNO
and then 1 mM GSH for different time intervals.
Western blot bands are labeled as either GSH-
unstable (open arrowheads) or GSH-stable
(closed arrowheads).
(C) Expansion of boxed region in (B) shows two
S-nitrosylated proteins that display significantly
different levels of GSH stability even though both
proteins originally display comparable levels of
GSNO-induced S-nitrosylation.
(D) Densitometry measurements of the results in (B). Band intensity was compared at 0 and after 30 min of GSH treatment to quantify the degree of GSH-
mediated denitrosylation. The number of S-nitrosylated proteins that exhibit the indicated degree of denitrosylation are shown. Proteins generally were either
highly stable in the presence of GSH (i.e., exhibiting less than 20% denitrosylation), or they were highly susceptible to GSH (i.e., exhibiting greater than 80%
denitrosylation). Most proteins were highly sensitive to GSH-mediated denitrosylation. Densitometry was averaged from three independent experiments.
(E) Protein conformation stabilizes nitrosothiols in GSH-stable proteins. Lysates were exposed to GSNO and then either 1 mM GSH or 2-ME, with or without 1%
SDS in the buffer. The small reducing agent 2-ME exhibited more denitrosylation than GSH. Denitrosylation was highly effective in the presence of the denaturant
SDS.1308 Chemistry & Biology 15, 1307–1316, December 22, 2008 ª2008 Elsevier Ltd All rights reserved
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Proteomic Profiling of S-Nitrosylationproteins with 2-ME did not result in substantially more denitrosy-
lation than GSH (Figure 1E). However, inclusion of the protein
denaturating agent sodium dodecyl sulfate (SDS) with 2-ME in
the denitrosylation solution resulted in complete denitrosylation
of all proteins (Figure 1E). In principle, a simple transnitrosylation
reaction is expected to exhibit complete chemical reversibility.
The existence of S-nitrosylated proteins that are incapable of be-
ing reversibly denitrosylated implies additional thermodynami-
cally favorable steps, such as conformational changes, that
occur after S-nitrosylation in these proteins. The experiments
above suggest that protein structure might limit the accessibility
of the nitrosothiol to the solvent or otherwise reduce the reactiv-
ity of the nitrosothiol, accounting for the decreased ability of
these nitrosothiols to be reduced.
A Proteomic Method for Identification
and Quantification of S-Nitrosylation
Wenext sought to identify proteins that have the capacity to form
stable nitrosothiols. A small pool of stable protein nitrosothiols is
found constitutively in cells, as exemplified by mitochondrial
caspase-3 (Mannick et al., 1999) and more recently by the
work of Chvanov and colleagues (Chvanov et al., 2006). Because
previous studies focused on specific proteins, we sought to
identify stable protein nitrosothiols without any biases toward
their identity. Currently, there are no methods that permit the rel-
ative quantification of protein nitrosothiols on a proteome-wide
scale. We decided to adapt the isotope-coded affinity tag
(ICAT) technique (Gygi et al., 1999), which utilizes isotopically la-
beled protein-modifying agents in conjunction with liquid chro-
matography tandem mass spectrometry (LC-MS/MS) to identify
and quantify expression level differences of proteins in two
distinct samples. We synthesized SNOCAP (S-nitrosothiol cap-
ture) reagents based on N-(6-(biotinamido)hexyl)-30-(20-pyridyl-
dithio)-propionamide (biotin-HPDP), the activated mixed disul-
fide reagent used to selectively label nitrosylated thiols in the
biotin switch method (Jaffrey et al., 2001). SNOCAP reagents
were synthesized in ‘‘light’’ and ‘‘heavy’’ forms and comprise
three parts: (i) a cysteine-reactive activated mixed disulfide; (ii)
a linker that contains either zero (light) or four atoms (heavy) of
the heavy isotopes of carbon (13C) and nitrogen (15N); and (iii) a
biotin moiety that is used to recover peptides on immobilized
neutravidin (Figure 2A). SNOCAP (Figures 2B and 2C) is used
to compare two samples and is based on the biotin switch
method, which was recently confirmed to be highly specific for
nitrosothiols (Forrester et al., 2007).
In control experiments, we assessed whether the SNOCAP
procedure labels nonnitrosylated proteins. To test this we
treated prereduced brain lysates with either vehicle or GSNO,
and then labeled the samples with light and heavy SNOCAP
reagents, respectively. After processing the samples according
to the SNOCAP protocol, over 100 S-nitrosylated proteins
were identified by MS/MS (Table S2). Importantly, in each
case, there was no peptide ion present from the vehicle-treated
sample; all ions were detected as the heavy-labeled peptide de-
rived from the GSNO-treated sample (Figure S2). These results
indicate that SNOCAP, like the biotin switch method (Forrester
et al., 2007), does not result in artifactual labeling from incom-
plete thiol blockage. Although biotinylated peptides increase
the complexity of MS/MS spectra due to biotin-derived fragment
ions (Tao and Aebersold, 2003), y- and b-ions derived from
fragmentation of SNOCAP-labeled peptides were still readily
detectable in MS/MS spectra (Figure 3A).
To determine whether SNOCAP can accurately measure rela-
tive S-nitrosylated protein abundance in two different samples,
we prepared mixtures of hemoglobin (Hb) and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), two well-established
targets of NO (Hara et al., 2005; Jia et al., 1996), at known but
different concentrations. After nitrosylation, the mixtures were
labeled with either the light or heavy SNOCAP reagents, and
processed according to the SNOCAP protocol. The isolated
C
B
A Figure 2. SNOCAP Method for Quantitative
Nitrosoproteomics
(A) Structure of the SNOCAP reagent. The
SNOCAP reagent is composed of three parts:
a thiol-reactive activated mixed disulfide, an
isotope-coded linker, and a biotin moiety used
for recovery. Carbon and nitrogen atoms that are
incorporated into SNOCAP reagents in isotopi-
cally light or heavy forms are labeled (*).
(B) Schematic diagram of the SNOCAP method. A
theoretical protein is indicated with cysteines in
either the free-thiol, disulfide, or nitrosothiol con-
formation. In step 1, free thiols are blocked by
methylthiolation with MMTS. In step 2, MMTS is
removed by acetone precipitation, and nitroso-
thiols are selectively reduced with ascorbate to
reform the thiols. In step 3, newly formed thiols
are isotopically labeled and biotinylated with the
SNOCAP reagent. Proteins are then digested
with trypsin in step 4 and biotinylated peptides
are recovered using neutravidin in step 5.
(C) Strategy for use of the SNOCAP method to
quantitatively compare S-nitrosylation between
two samples.Chemistry & Biology 15, 1307–1316, December 22, 2008 ª2008 Elsevier Ltd All rights reserved 1309
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Proteomic Profiling of S-Nitrosylationpeptides, corresponding to the original nitrosopeptides, were
then quantified and sequenced by LC-MS/MS. The measured
ratios of both the GAPDH and Hb-derived peptides were consis-
tent with the ratios of each protein in the original two samples
(Table S1).
Identification of Stable Nitrosoproteins by Proteomic
Profiling of Nitrosothiol Reactivity
We next used the SNOCAP strategy to survey the reactivities of
nitrosothiols in proteins. In these experiments, a preparation of
S-nitrosylated proteins was made using GSNO. Because our
goal was tomonitor the denitrosylation of dozens of protein nitro-
sothiols simultaneously, we needed the cysteines of as many
previously described nitrosoproteins to beS-nitrosylated to a de-
gree sufficient for detection. Although some proteins are more
efficiently S-nitrosylated by specific transnitrosylating molecules
other than GSNO, to the best of our knowledge, there is no pro-
tein nitrosothiol that cannot be elicited to some degree byGSNO.
Nitrosylated proteins were incubated with either vehicle
(GSNO/vehicle) or 1 mM GSH (GSNO/GSH) for 5 min.
Next, the protein nitrosothiols in the GSNO/vehicle sample
and the GSNO/GSH sample were labeled with light and heavy
SNOCAP reagents, respectively.
MS/MS analysis of these samples identified 102 S-nitrosy-
lated proteins, some of which exhibited multiple sites of S-nitro-
sylation (Table S2 and Figure S3). Of these proteins, 50 have
previously been shown to be S-nitrosylated (Table S2). The sites
of S-nitrosylation that we identified also matched previously
reported sites in the few instances where the specific site of
S-nitrosylation has already been identified and biochemically
confirmed (Table S2). It should be noted that some proteins
that have been described to be susceptible to S-nitrosylation
were not detected in our screen. This might reflect the low abun-
dance of these proteins in the cytosolic fraction of brain homog-
enates, such as ras (Mizoguchi et al., 1989) and thioredoxin
(Holmgren and Luthman, 1978), and the low abundance of these
proteins in brain compared with other tissues, such as caspase-
3 (Krajewska et al., 1997). Additionally, disulfide bonds can im-
pair trypsin cleavage, resulting in larger peptides and impaired
peptide detection. Because the SNOCAP method does not in-
volve a disulfide reduction step, cysteines that fall within tryptic
peptides containing disulfide bonds might also be missed. Addi-
tionally, MS/MS analysis can be incomplete because certain
peptides do not ionize or fragment efficiently (Elias and Gygi,
2007; Mallick et al., 2007), and the peptides identified can vary
significantly depending on the MS instrument and the search
algorithm used (Elias et al., 2005).
The majority of nitrosothiols identified were unstable in the
presence of GSH, as evidenced by the marked reduction in the
intensity of the heavy peak, which derives from the sample deni-
trosylated with GSH. In these cases, this peak was 20% or less
than the intensity of the light peak, which derives from the sam-
ple treated with vehicle (Figure 3B). These results indicate that
the nitrosothiol in these proteins were quantitatively reduced
by GSH treatment. However, for 11 of the peptides, both the
heavy and light peptide ions were nearly the same intensity,
with the heavy peak being at least 80% the intensity of the light
peak (Figure 3C). These peptides, which correspond to GSH-
stable sites of S-nitrosylation, are listed in Table 1. Each of these
proteins contain only one stably modified cysteine with the
exception of GAPDH, which possessed two cysteines capable
of stable S-nitrosylation. Interestingly, several of the proteins in
Table 1 contained additional S-nitrosylated cysteines that were
not stable to GSH treatment (Figures 3D and 3E and Table S2),
indicating that nitrosothiols within the same protein can have
different reactivity. These data indicate that a small subset of
protein nitrosothiols exhibit markedly reduced reactivity com-
pared with the majority of protein nitrosothiols.
Biochemical Confirmation and Structural Analysis of MS
Characterized S-Nitrosylation Sites
We next used in vitro denitrosylation assays to biochemically
confirm the results of the MS experiments. Brain lysate was
S-nitrosylated as above, and then denitrosylated by treatment
with vehicle or 1 mM GSH for 5 min. The proteins that remained
S-nitrosylated were then purified using the biotin switch method
B C
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Figure 3. Quantitative MS Identifies Sites of S-Nitrosylation and
Reveals Differences in GSH-Mediated Denitrosylation of These Sites
(A) Representative collision-induced dissociation spectra showing the MS/MS
peaks of a SNOCAP-labeled peptide from CRMP-2 with the y-ion series, b-ion
series, and the precursor ion labeled.
(B,C) MS spectra of isolated S-nitrosylated peptides reflect large differences in
susceptibility to GSH-induced denitrosylation. The majority of S-nitrosylated
peptides appear highly unstable in the presence of GSH, as seen with the
MS spectra of a peptide derived from 14-3-3 q showing 92.7% denitrosylation
(B). A small subset of peptides appears highly stable to GSH, as seen by
MS spectra of peptide isolated from GST-pi showing only 10.4% denitrosyla-
tion (C).
(D,E) Several proteins contained multiple cysteines that undergo S-nitrosyla-
tion, but only a single cysteine capable of stable nitrosylation. MS spectra of
two peptides isolated from CRMP-2 are shown with differential stability to
GSH.One peptide is highly susceptible to denitrosylation (D) whereas the other
undergoes negligible denitrosylation (E).1310 Chemistry & Biology 15, 1307–1316, December 22, 2008 ª2008 Elsevier Ltd All rights reserved
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Proteomic Profiling of S-Nitrosylation(Jaffrey et al., 2001). Proteins for which antibodies are readily
available were selected for biochemical validation. The S-nitro-
sylated proteins that were identified by MS as GSH-unstable
were essentially absent in GSH-treated samples, indicating
that they were rapidly denitrosylated upon treatment with GSH
(Figure 4A). In contrast, the S-nitrosylated proteins identified
by MS as GSH-stable remained robustly nitrosylated under the
same conditions (Figure 4B). In the case of b-tubulin and
CRMP-2, the band seen for GSNO/GSH samples is slightly
less intense than the band seen for GSNO/vehicle treated
samples, which is consistent with our finding that only one of
the several nitrosylation sites is stable on these proteins (see
Figures 3D and 3E and Table S2).
Our biochemical experiments to probe the solvent accessibil-
ity of protein nitrosothiols suggest that S-nitrosylation is coupled
to conformational changes that lead to reduced nitrosothiol ac-
cessibility. Thus, we next asked if the structural context could
account for the reduced reactivity of the stable protein nitroso-
thiols. Examination of the crystal structures of some of the stably
S-nitrosylated proteins in their unnitrosylated states suggests
that a variety of structural mechanisms might affect nitrosothiol
reactivity. In some cases, the cysteines that form stable nitroso-
thiols are fully solvent exposed (Figures S4–S6), and the solvent
accessibility was indistinguishable from other cysteines that
form unstable nitrosothiols (Figures S5 and S6). However, in
other cases, the cysteine is found within grooves or between
large mobile lobes of the proteins that could potentially undergo
small conformational changes that would effectively shield a
nitrosothiol (Figures S6 and S7).
GSH-Stable Nitrosothiols Are Also Stable in Cells
Wenext wanted to determine if the nitrosothiols that are stable to
reduction by GSH in vitro are also stable in the complex reducing
environment in living cells. To test the stability of S-nitrosylated
proteins in cells, we used sEnd.1 murine endothelioma cells,
which express eNOS and generate NO under basal conditions
(Ghigo et al., 1995). Using the biotin switch method to label
S-nitrosylated proteins in sEnd.1 cells, we found that proteins
that were unstable to GSH in vitro were only minimally S-nitrosy-
lated in unstimulated sEnd.1 cells (Figure 5A). S-nitrosylation
could be more readily detected by pretreatment for 10 min
with the calcium ionophore A23187, which activates eNOS
(Figure 5A). The nitrosothiols in these proteins appeared to
be unstable in cells because application of the NOS inhibitor
N-nitro-L-arginine methyl ester (L-NAME) for 5 min to A23187-
treated cells resulted in markedly reduced levels of S-nitrosy-
lated protein compared with vehicle application to A23187-
treated cells. Thus, these protein nitrosothiols were unstable to
both in vitro application of GSH and to the physiologic reducing
environment in cells.
We next examined the cellular stability of nitrosoproteins that
were stable to GSH in vitro. Unlike the GSH-unstable proteins,
these proteins were readily detectable as S-nitrosylated
in sEnd.1 cells. Additionally, treatment of these cells with
L-NAME did not substantially alter nitrosothiol levels in these
proteins (Figure 5B and S8). As a control, in prereduced
sEnd.1 lysates, nitrosothiols were undetectable, confirming the
specificity of the biotin switch assay (Figure 5B). Taken together,
these data indicate that endogenous nitrosothiol stability, even
after NO synthesis is inhibited, is a feature of only a subset of
S-nitrosylated proteins.
DISCUSSION
S-nitrosylation is a major mechanism by which NO signals in
cells. Much of our current understanding of the properties of
nitrosothiols comes from studies of low molecular weight nitro-
sothiols. These studies indicate that nitrosothiols are highly labile
and susceptible to reduction by thiol-containing molecules,
including molecules that are present at millimolar concentrations
in the cytosol. Our studies indicate that there are certain in-
stances in which nitrosothiols that form in proteins do not exhibit
the predicted high degree of reactivity. We find that there are two
separate types of nitrosothiols that can exist in proteins—stable
and unstable nitrosothiols—and that the stabilization of nitroso-
thiols is conferred by conformational changes that shield the ni-
trosothiol from cytosolic reducing agents. Stably S-nitrosylated
proteins might have selectively evolved to withstand the highly
reducing cytosolic milieu, thus allowing them to transduce NO
signals after ambient NO levels have dropped. Reduction of
Table 1. Proteins Resistant to GSH-Mediated Denitrosylation
Protein Name Peptide Sequence Identifieda Percent Reduction in S-Nitrosylationb (Mean ± SD)c
a-Tubulin AYHEQLSVAEITNACFEPANQMVK 11.8% ± 2.3
b-Tubulin EIVHIQAGQCGNQIGAK 15.2% ± 3.6
Collapsin response mediator protein 2 GLYDGPVCEVSVTPK 11.8% ± 2.1
Creatine kinase, b chain FCTGLTQIETLFK 16.3% ± 3.4
Extracellular signal-regulated kinase 2 DLKPSNLLLNTTCDLK 14.8% ± 2.9
Glutathione S-transferase pi EAALVDMVNDGVEDLRCK 16.6% ± 3.8
Glyceraldehyde-3-
phosphate dehydrogenase
VPTPNVSVVDLTCR
IVSNASCTTNCLAPLAK
7.3% ± 2.3
13.1% ± 2.3
Hemoglobin, b chain GTFAHLSELHCDK 16.5% ± 4.8
Pyruvate kinase AGKPVICATQMLESMIK 7.3% ± 3.6
Peroxiredoxin-6 DFTPVCTTELGR 8.5% ± 3.7
aModified cysteine residues are highlighted by bold lettering.
b Total denitrosylation in the presence of 1 mM GSH for 5 min.
c These values represent the average of five experimental samples with each sample being reloaded and quantified by LC-MS/MS three to six times.Chemistry & Biology 15, 1307–1316, December 22, 2008 ª2008 Elsevier Ltd All rights reserved 1311
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such as the thioredoxin/thioredoxin reductase or GSNO reduc-
tase pathways (Benhar et al., 2008; Whalen et al., 2007).
Our studies suggest that stable and unstable nitrosothiols may
have different roles in NO signaling. Unlike the small set of stable
nitrosoproteins, most nitrosoproteins were not stable in the pres-
ence of physiological concentrations of GSH and were only min-
imally S-nitrosylated endogenously, consistent with studies of
small-molecule nitrosothiols (Kashiba-Iwatsuki et al., 1997;
Singh et al., 1996). Although nitrosothiols in these proteins
were undetectable under basal cellular conditions, they showed
significant increases in S-nitrosylation when cellular levels of NO
were high, suggesting that signaling by these proteins may be
more transient and linked directly to the duration of NO synthe-
sis. Alternatively, these nitrosothiols might accumulate under
certain circumstances, such as during oxidative stress, when
the reducing potential of the cell is compromised (Beltran
et al., 2000). Our finding that a subset of proteins can exist as
S-nitrosylated species in the presence of substantial concentra-
tions of GSH in vitro and in cells after inhibition of endogenous
NOS activity raises the possibility that these proteins are capable
of accumulating stoichiometric levels of nitrosothiols in cells,
thereby quantitatively affecting protein function.
A
B
Figure 4. Biochemical Confirmation ofMS-Characterized S-Nitrosy-
lation
(A) S-nitrosylated proteins identified by SNOCAP as being GSH-unstable are
reduced by GSH in vitro. Brain lysates were nitrosylated with 40 mM GSNO
and then treated with either vehicle (GSNO/vehicle) or 1 mM GSH
(GSNO/GSH). After 5 min, S-nitrosylated proteins were then biotinylated
using the biotin switchmethod, purified on immobilized neutravidin, and eluted
using 2-ME. Eluates were blotted with the indicated antibodies.
(B) GSH-stable S-nitrosylated proteins identified by SNOCAP are resistant to
reduction by GSH in vitro. S-nitrosylated proteins generated by GSNO treat-
ment were treated with either vehicle (GSNO/vehicle) or GSH (GSNO/
GSH) and assayed as in (A). In each case, the proteins remained S-nitrosylated
after GSH treatment.
A
B
Figure 5. Identification of Stably S-Nitrosylated Proteins in Cells
(A) GSH-unstable proteins form labile nitrosothiols in sEnd.1 cells. sEnd.1 cells
were treated with either vehicle (ethanol) or 10 mM A23187 for 10 min followed
by either vehicle (media) or 1mML-NAME for 5min. Cellswere lysed and a total
of 50 mg protein was collected for each sample. S-nitrosylated (SNO) proteins
were biotinylated using the biotin switch method, purified and eluted, and an-
alyzed by western blotting with indicated antibodies. GSH-unstable proteins
were S-nitrosylated at a low stoichiometry in vehicle-treated cells (vehicle/
vehicle), but readily detectable in cells pretreated for 10 min with A23187. Pro-
teins remained S-nitrosylated if vehicle was added to the ionophore-treated
cells (A23187/vehicle), but were no longer S-nitrosylated after 5 min of
L-NAME treatment (A23187/L-NAME), indicating that these proteins were
not stably S-nitrosylated in cells after inhibition of NO synthesis. These effects
do not reflect changes in expression levels in sEND.1 cells as the total protein
levels were unaffected in the loading controls.
(B) GSH-stable proteins remain S-nitrosylated in cells after inhibition of NO
synthesis. Proteins found to be GSH-stable in in vitro experiments were readily
found to be S-nitrosylated in vehicle (media)-treated sEnd.1 cells. These
proteins remained S-nitrosylated even in cells that were treated with 1 mM
L-NAME for 5 min. No protein labeling was detected in sEnd.1 samples that
were prereduced with DTT.1312 Chemistry & Biology 15, 1307–1316, December 22, 2008 ª2008 Elsevier Ltd All rights reserved
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nously S-nitrosylated proteins from various cell types using pro-
teomic approaches. However, these studies have resulted in the
detection of surprisingly few endogenously S-nitrosylated pro-
teins (J.S.P. and S.R.J., unpublished data; Gao et al., 2005;
Hao et al., 2006; Martinez-Ruiz and Lamas, 2004), despite the
large number of S-nitrosylated proteins that have been reported
in the literature. These endogenously S-nitrosylated proteins in-
clude a-tubulin, b-tubulin, CRMP-2, and GAPDH. Notably, these
proteins are also stably S-nitrosylated. This suggests that these
proteins were detected because of the stability of their nitroso-
thiols and the ability of these nitrosothiols to accumulate to levels
that could be detected by MS methods. None of the proteins
found to be endogenously S-nitrosylated in these prior studies
were found to contain unstable nitrosothiols in our study. To-
gether, these data provide further support to the idea that stable
S-nitrosylation is a feature of certain proteins in vivo.
The basis for the stability of these protein nitrosothiols is not
readily apparent from the crystal structures of the unnitrosylated
forms of the proteins. In some cases the cysteines were partially
buried, suggesting that minor conformational changes induced
by S-nitrosylation could effectively shield the nitrosothiol. How-
ever, in several cases, the S-nitrosylated cysteine was situated
in such a way that it is unclear how it could be shielded from
reducing agents. Crystal structures of the S-nitrosylated forms
of these proteins will be required to identify the S-nitrosylation-
induced conformational changes that bury the nitrosothiol. The
idea that S-nitrosylation promotes conformational changes that
stabilize nitrosothiols is well demonstrated in Hb, where S-nitro-
sylation of Cysb93 promotes a conformational change in which
the nitrosothiol is buried in a hydrophobic pocket where it is in-
accessible to solvent (Singel and Stamler, 2005). Deoxygenation
Hb reverses this conformational change, increasing the reactivity
of S-nitroso-Hb to GSH (Singel and Stamler, 2005). However, an
additional mechanism thatmight account for nitrosothiol stability
is the presence of associated proteins that reduce solvent
access to the nitrosothiol. In Erk-2, the nitrosylated cysteine is
present on a surface that is associated with numerous protein-
protein interactions (Tanoue et al., 2000). In agreement with
this idea, S-nitrosylation of GAPDH results in increased interac-
tions with other proteins (Hara et al., 2005). An additional factor
that should be considered is the cis/trans conformation of the
nitrosothiol, which could affect the overall rate of nitrosothiol
reduction (Stamler and Toone, 2002; Weichsel et al., 2007).
Conceivably, nitrosothiol stability might be influenced by
protein-mediated stabilization of specific cis/trans nitrosothiol
isoforms.
The stably nitrosylated proteins identified in this study corre-
spond to several proteins widely studied as NO effectors in cells,
including GAPDH, creatine kinase, and Hb. S-nitrosylation of
GAPDH has been shown to mediate NO-induced apoptotic
death (Hara et al., 2005). Creatine kinase also undergoes S-nitro-
sylation, leading to a decrease in Ca2+ uptake in the sarcoplas-
mic reticulum (Wolosker et al., 1996), which is thought to contrib-
ute to inhibition of mitochondrial respiration (Stamler and
Meissner, 2001). S-nitrosylation of Hb in cells has a well-estab-
lished role in the regulation of blood flow (Stamler et al., 1997a)
and platelet aggregation (Pawloski et al., 1998). We also identi-
fied several proteins that have not been rigorously linked to NO
signaling in cells, such as a-tubulin, b-tubulin, CRMP-2, and
Erk-2. However, these proteins are involved in pathways and
processes that are affected by NO in cells. For example, NO
has been shown to impair dendrite outgrowth (Inglis et al.,
1998) and elicit cytoskeletal breakdown via microtubule destabi-
lization in cerebellar granule cells (Bonfoco et al., 1996), which
might reflect S-nitrosylation of tubulin subunits or CRMP-2, a mi-
crotubule regulatory protein. Similarly, we found Erk-2 to be
stably nitrosylated, which is consistent with the regulatory role
of NO in several mitogen-activated protein kinase pathways
(Hess et al., 2005). Together, the stably nitrosylated proteins
identified here represent both important physiological targets
of NO and proteins that are involved in pathways mediated by
NO in cells.
The degree to which a nitrosothiol accumulates on a cysteine
residue in a protein is determined by the balance between the
rates of S-nitrosylation and denitrosylation. Our data highlight
the importance of denitrosylation pathways in regulating the
steady-state level of nitrosothiols on proteins. For certain
proteins, the critical factor determining the nitrosothiol stoichi-
ometry at each cysteine might be the accessibility of the nitroso-
thiol to physiologic reducing agents. S-nitrosylation by GSNO or
nitrosating agents such as N2O3 might occur on numerous cys-
teine residues and then be rapidly reversed on all but the few
cysteines that have the unusual property of undergoing stable
modification. Conceivably, certain proteins evolved the ability
to bury the modified cysteine in order to allow NO, an otherwise
ephemeral signaling molecule, to have a long-lasting effect in
cells.
SIGNIFICANCE
Previous work established that caspase-3 forms a protein
nitrosothiol that cannot be denitrosylated by GSH (Mitchell
andMarletta, 2005). However, it was unclear from this earlier
study whether nitrosothiols in other S-nitrosylated proteins
exhibit this property. In this study, we designed a quantita-
tive nitrosoproteomic approach to screen dozens of previ-
ously characterized, as well as novel protein nitrosothiols
for their chemical reactivity with reducing agents. Our re-
sults indicate that although most S-nitrosylated proteins
are rapidly degraded by reducing agents, there is a novel
class of NO targets that are capable of forming stable nitro-
sothiols. These stable nitrosothiols also exhibit exceptional
stability in vivo. Some of these proteins are well-established
NO targets, suggesting that physiologic NO signaling uti-
lizes stable nitrosothiols. The inability of these proteins to
be reduced by GSH, as is the case with caspase-3, raises
the possibility that these proteins will utilize highly specific
intracellular denitrosylation pathways that regulate the
circumstances and degree to which these nitrosothiols
accumulate after NO signaling.
EXPERIMENTAL PROCEDURES
Denitrosylation Assay
Freshly isolated rat cerebellum was homogenized in 10 volumes of HEN buffer
(25mMHEPES [pH 7.7], 1 mMEDTA, and 10 mMneocuproine) and then centri-
fuged at 20,000g for 15 min at 4C. The supernatant typically containedChemistry & Biology 15, 1307–1316, December 22, 2008 ª2008 Elsevier Ltd All rights reserved 1313
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added 5 ml GSNO stock (400 mM in water) or vehicle to make the final concen-
tration of NO donor in each sample 40 mM, and the mixture was incubated for
20 min at 25C. After this step, residual GSNO was removed by centrifuging
the lysate through a MicroBioSpin6 column (BioRad) pre-equilibrated in HEN
buffer. To the desalted protein lysate was added 5 ml GSH stock (11 mM in wa-
ter) or vehicle to make the final concentration of GSH 1 mM, and the mixture
was incubated at 25C for 5, 10, or 30 min. To the denitrosylated samples
was then added four volumes of blocking buffer (nine volumes of 10X HEN
buffer plus one volume 20% SDS, adjusted to 20 mMMMTS with a 2 M stock
prepared in dimethylformamide (DMF) at 50C for 20 min with frequent vortex-
ing. The proteins were then precipitated with two volumes of acetone at20C
for 1 hr. After centrifugation, the protein pellet was washed six times with cold
acetone to remove residual MMTS. Pellets were then resuspended in 125 ml
HENS buffer (HEN with 1% SDS). To the resuspended proteins was added bi-
otin-HPDP prepared fresh as a 4 mM stock in dimethylsulfoxide from a 50 mM
stock suspension in DMF. Sodium ascorbate was added in a final volume of
2 ml to a final concentration of 2 mM. After incubation for 1 h at 25C,
SDSPAGE sample buffer was added and the samples (without reduction
or boiling) were resolved by SDSPAGE and transferred for immunoblotting.
All steps preceding SDS-PAGE were carried out in the dark.
To evaluate the role of protein structure on denitrosylation, nitrosylated
proteins were prepared with GSNO as described above. Next, to the lysates
was added either 5 ml GSH or 2-ME stock (11 mM) prepared in either water
or 11% SDS, making the final concentration of GSH and 2-ME 1 mM, and
the final SDS concentration 1%. The colorimetric thiol probe, DTNB, was
used to confirm that stock solutions of GSH and 2-ME contained equal
amounts of free thiol. Samples were then analyzed using the biotin switch
method as described above.
SNOCAP Analysis of Standard S-Nitrosylated Protein Mixtures
GAPDH and Hb (Sigma) were resuspended in HEN buffer to a concentration of
1 mg/ml. The protein solutions were then reduced with 50 mM DTT and dia-
lyzed, and the two protein stocks were combined in two samples of different
concentrations. To each sample was then added GSNO to a final concentra-
tion of 40 mM and the samples were incubated for 20 min at 25C. Residual
GSNO was removed by centrifuging the suspension through a MicroBioSpin6
column pre-equilibrated in HEN buffer, and to the eluate was added four
volumes of blocking buffer. After blocking and precipitation as described
above, the samples were resuspended in HENS buffer with 2 mM sodium
ascorbate and incubated with 1 mM of either light or heavy SNOCAP reagent
for 1 hr at 25C. Proteins were again acetone precipitated to remove SDS and
pelleted by centrifugation. The two samples were then resuspended in HEN
buffer with 8 M urea and combined. The combined sample was diluted to
1.2 M urea and digested with trypsin (1:25) overnight at 37C. Trypsin was in-
hibited with 1 mM phenylmethyl sulfonyl fluoride and 1 mM leupeptin, and the
digest was passed over 250 ml pre-equilibrated neutravidin resin (Pierce). The
resin was washed with 2X PBS twice, 1X PBS four times, and 20% MeOH
twice. Biotinylated peptides were eluted with 1 ml acetonitrile:water:trifluoro-
acetic acid (50:50:0.1, vol/vol/vol). Samples were then concentrated to
100 ml under reduced pressure and approximately 1 pmol peptide, as deter-
mined by fluorescamine assay, was injected and analyzed by nLC-MS/MS.
The entire procedure (SNOCAP and LC-MS/MS) can be completed in 1–
2 days, allowing for the rapid analysis of dozens or hundreds of nitrosoproteins
compared with the time-consuming analysis of individual nitrosoproteins.
Profiling of Stably S-Nitrosylated Proteins
Six hundred milligrams of rat brain was homogenized as described above pro-
viding approximately 30 mg protein. The homogenate was divided into two
equal samples and incubated with 40 mM GSNO for 20 min. Residual GSNO
was removed by gel filtration using MicroBioSpin6 columns. To the eluate
was added GSH or vehicle to a final concentration of 1 mM and the mixture
was incubated at 25C for 10min. Proteins were then blocked, acetone precip-
itated, and resuspended in HENS buffer as described above. Nitrosothiols
were then reduced with sodium ascorbate (2 mM) and labeled with either
1 mM light SNOCAP reagent (GSNO/vehicle-treated sample) or 1 mM heavy
SNOCAP reagent (GSNO/GSH-treated sample). Proteins were next di-
gested, biotinylated peptides recovered, and analyzed using nLC-MS/MS as
described above. This experiment was repeated five times and each sample
was reloaded and analyzed by LC-MS/MS three to six times. In control exper-
iments using ‘‘prereduced’’ lysates, the cytosolic lysate was adjusted to
20 mM dithiothreitol and then dialyzed against 1X HEN buffer two times before
performing SNOCAP.
LC-MS/MS and Quantitative Analysis
LC-MS/MS was performed on an XCT ion trap mass spectrometer (Agilent) as
described in the Supplemental Experimental Procedures.
Peptide Sequence Identification
Analysis of MS/MS spectra for peptide identification was performed by protein
database searching with SPECTRUM MILL software (Agilent Technologies).
The threshold used for peptide identification was a SPECTRUM MILL score
of > 9.0 and an SPI% (the percentage of assigned spectrum intensity of total
spectrum intensity) of > 60%. This threshold was established by searching
the same data against two different decoy databases. One decoy database
contained reversed rat protein sequences whereas the other contained com-
pletely scrambled protein sequences. The scrambled database contained the
same number of total proteins with same number of amino acids for each pro-
tein as found in the original database. The scrambled sequences were gener-
ated based on the relative abundance of each type of amino acid in the whole
rat protein database. Scores of the hits obtained using these decoy databases
identify the threshold scores needed to reduce the likelihood of false positives
(Elias and Gygi, 2007). In these experiments, the false-positive rate for a score
of > 9.0 and an SPI > 60% was 1.72%. All hits were validated by manual
inspection of the raw MS/MS data. Additional details are provided in the
Supplemental Experimental Procedures.
Purification of S-Nitrosylated Proteins for Biochemical Confirmation
Ten milligrams of brain lysates were nitrosylated with 40 mM GSNO and then
treated with either vehicle or 1mMGSH. Any S-nitrosylated cysteines residues
were then labeled with biotin by the biotin switchmethod. Biotinylated proteins
were poured over immobilized neutravidin, the resin was washed, and S-nitro-
sylated proteins were specifically eluted with 2-ME. Approximately 20% of
each eluate was then analyzed by western blotting using antibodies to b-tubu-
lin (Developmental Studies Hybridoma Bank), GAPDH (Millipore), ERK-2
(Santa Cruz Biotechnologies), CRMP-2 (Millipore), GST-pi (Genscript), hnRNP
(Santa Cruz Biotechnologies), 14-3-3 q (Cell Signaling), and EF-1a (Upstate).
Purification of Endogenously S-Nitrosylated Proteins
Murine sEnd.1 cells were grown on plastic culture dishes in high-glucose
DMEM (Invitrogen) supplemented with 10% fetal calf serum (Invitrogen) for
24–48 hr before lysing cells and labeling S-nitrosylated proteins with the biotin
switch method. For these experiments, approximately 50 mg protein was
extracted from cells for each sample. Transiently S-nitrosylated proteins
were labeled after treating cells with either vehicle or 10 mM A23187 for
10 min, followed by treatment with vehicle or 1 mM L-NAME for 5 min. Stably
S-nitrosylated proteins were labeled after treating cells with either vehicle or
1 mM L-NAME for 5 min. Before the biotin switch, some lysates were prere-
duced with 50mMDTT, which was subsequently removed by dialysis. Biotiny-
lated proteins were poured over immobilized neutravidin, the resin was
washed, and S-nitrosylated proteins were specifically eluted with 2-ME.
Approximately 20% of the volume from each eluate was then analyzed by
western blotting using antibodies described above as well as antibodies to
a-tubulin (Developmental Studies Hybridoma Bank) and DJ-1 (Millipore).
Crystal Structure and Solvent Accessible Area Analysis
The images of Erk-2, GST-pi, a-/b-tubulin, and GAPDH crystal structures were
made using PyMOL. The solvent accessibility area of the sulfurs was calcu-
lated using the program NACCESS (Hubbard et al., 1991) with a probe of
1.4 A˚.
Accession Numbers
Protein Data Bank (PDB) identifiers: accession codes: human Erk-2, 1TVO;
human GAPDH, 1ZNQ; pig a-/b-tubulin dimer, 1TUB; human GST-pi dimer,
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